This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swanson, C. Articles by Lerner, U. H. Search for Related Content PubMed PubMed Citation Articles by Swanson, C. Articles by Lerner, U. H.

Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-B (NF-B) Ligand, Osteoprotegerin, and Receptor Activator of NF-B in Mouse Calvarial Bones

Department of Oral Cell Biology (C.S., H.H.C., U.H.L.), Umeå University, SE-901 87 Umeå, Sweden; Center for Bone Research at the Sahlgrenska Academy (C.S., M.L.), Department of Internal Medicine, Göteborg University, SE-413 45 Göteborg, Sweden; and Department of Physiology and Biophysics (H.H.C.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Professor Ulf H. Lerner, D.D.S., Ph.D., Department of Oral Cell Biology, Umeå University, Umeå SE-901 87, Sweden. E-mail: ulf.lerner{at}odont.umu.se.

In the present study, dexamethasone treatment of neonatal mouse calvarial bones increased mRNA expression of tartrate-resistant acid phosphatase, calcitonin receptor (CTR), cathepsin K, carbonic anhydrase II, osteoprotegerin (OPG), and receptor activator of nuclear factor-B (RANK) as well as mRNA and protein expression of RANK ligand (RANKL). The increase in OPG mRNA noted with dexamethasone was in contrast to 1,25(OH)₂-vitamin D3 (D3) treatment, which decreased OPG expression. Stimulation of ⁴⁵Ca release by dexamethasone and hydrocortisone in calvariae was blocked by OPG. Stimulation of RANKL, RANK, OPG, and CTR mRNA expression by dexamethasone in calvariae was blocked by the glucocorticoid receptor antagonist RU 38 486. Greater than additive potentiations of CTR mRNA and RANKL mRNA and protein were observed when D3 and dexamethasone were combined. Vitamin D receptor mRNA was increased by dexamethasone and D3, whereas glucocorticoid receptor (GR) mRNA was decreased by dexamethasone and unaffected by D3. No synergistic interaction between dexamethasone and D3 on either vitamin D receptor or GR mRNA expression was noted. The data demonstrate that dexamethasone-induced bone resorption in calvarial bones is associated with increased differentiation of osteoclasts and regulation of the RANKL-RANK-OPG system. The increase in OPG expression and the decrease of GR expression noted with dexamethasone offer an explanation for why bone breakdown in mouse calvariae treated with glucocorticoids is less than that caused by resorptive agents like D3. The synergistic stimulation of RANKL by dexamethasone and D3 offers an explanation of how glucocorticoids and D3 interact to potentiate bone resorption.

This article has been cited by other articles:

				L. Mancini, M. J. Paul-Clark, G. Rosignoli, R. Hannon, J. E. Martin, I. Macintyre, and M. Perretti Calcitonin and Prednisolone Display Antagonistic Actions on Bone and Have Synergistic Effects in Experimental Arthritis Am. J. Pathol., March 1, 2007; 170(3): 1018 - 1027. [Abstract] [Full Text] [PDF]